These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 945581

  • 1. Intraventricular 6-hydroxydopamine lowers isolation-induced fighting behavior in male mice.
    Crawley JN, Contrera JF.
    Pharmacol Biochem Behav; 1976 Apr; 4(4):381-4. PubMed ID: 945581
    [Abstract] [Full Text] [Related]

  • 2. [Intensified aggressivity of dominant male mice after the intraventricular administration of 6-hydroxydopamine].
    Serova LI.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988 Apr; 38(3):513-8. PubMed ID: 3142159
    [Abstract] [Full Text] [Related]

  • 3. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG, Beer B.
    Pharmacol Biochem Behav; 1975 Apr; 3(5):895-9. PubMed ID: 1208632
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Decreased anticonvulsant activity of carbamazepine in 6-hydroxydopamine-treated rats.
    Quattrone A, Samanin R.
    Eur J Pharmacol; 1977 Feb 07; 41(3):336-6. PubMed ID: 837975
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW, Sparber SB.
    J Pharmacol Exp Ther; 1974 Dec 07; 191(3):349-57. PubMed ID: 4427285
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of 6-hydroxydopamine on shock-elicited aggression, emotionality and maternal behavior in female rats.
    Sorenson CA, Gordon M.
    Pharmacol Biochem Behav; 1975 Dec 07; 3(3):331-5. PubMed ID: 1098058
    [Abstract] [Full Text] [Related]

  • 14. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B, Naylor RJ, Pycock C.
    Eur J Pharmacol; 1976 Feb 07; 35(2):276-83. PubMed ID: 942921
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of 6-hydroxydopamine to deplete brain catecholamines in the rhesus monkey: effects on urinary catecholamine metabolites and behavior.
    Kraemer GW, Breese GR, Prange AJ, Moran EC, Lewis JK, Kemnitz JW, Bushnell PJ, Howard JL, McKinney WT.
    Psychopharmacology (Berl); 1981 Feb 07; 73(1):1-11. PubMed ID: 6785782
    [Abstract] [Full Text] [Related]

  • 17. Development of ethanol tolerance not altered by 6-OHDA lesions of dorsal bundle.
    Steketee JD, Swann AC, Silverman PB.
    Pharmacol Biochem Behav; 1989 Jul 07; 33(3):729-31. PubMed ID: 2511577
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.